Share on StockTwits

Omeros (NASDAQ:OMER) released its earnings data on Monday. The company reported ($0.53) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.56) by $0.03, Stock Ratings News reports. The company had revenue of $0.45 million for the quarter, compared to the consensus estimate of $0.37 million. During the same quarter in the previous year, the company posted ($0.48) earnings per share. The company’s revenue for the quarter was up 221.4% on a year-over-year basis.

Omeros (NASDAQ:OMER) traded down 7.46% during mid-day trading on Tuesday, hitting $12.90. 731,490 shares of the company’s stock traded hands. Omeros has a 52 week low of $4.75 and a 52 week high of $18.80. The stock has a 50-day moving average of $14.87 and a 200-day moving average of $12.96. The company’s market cap is $437.5 million. Omeros also saw some unusual options trading activity on Tuesday. Stock investors bought 223 call options on the stock. This represents an increase of 132% compared to the typical daily volume of 96 call options.

Omeros Corporation operates as a biopharmaceutical company focused on the discovery, development and commercialization of products focused on inflammation and disorders of the central nervous system.

Receive News & Ratings for Omeros Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omeros Co and related companies with Analyst Ratings Network's FREE daily email newsletter.